High affinity antagonists of the vanilloid receptor

Molecular Pharmacology

Volumn 62, Issue 4, 2002, Pages 947-956

  Wang, Yun ^a,c   Szabo, Tamas ^a   Welter, Jacqueline D ^a   Toth, Attila ^a   Tran, Richard ^a   Lee, Jiyoun ^b   Kang, Sang Uk ^b   Suh, Young Ger ^b   Blumberg, Peter M ^a   Lee, Jeewoo ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Seoul National University   (South Korea)

^c PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; CAPSAICIN; CAPSAZEPINE; JYL 1421; KJM 429; LIGAND; N (4 TERT BUTYLBENZYL) N' [3 FLUORO 4 (METHYLSULFONYLAMINO)BENZYL]THIOUREA; N (4 TERT BUTYLBENZYL) N' [4 (METHYLSULFONYLAMINO)BENZYL]THIOUREA; PROTON; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; RESINIFERATOXIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VANILLOID RECEPTOR BLOCKING AGENT;

AGONIST; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CHO CELL; COMPARATIVE STUDY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG RESPONSE; HEAT SENSITIVITY; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; SPINAL CORD NERVE CELL; SPINAL GANGLION;

ANIMALS; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT; CALCIUM; CAPSAICIN; CELLS, CULTURED; CHO CELLS; CRICETINAE; DITERPENES; HEAT; NEURONS; PROTONS; RATS; RECEPTORS, DRUG; SULFONAMIDES; THIOUREA;

EID: 0036783709     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.4.947     Document Type: Article

References (40)

1. Appendino G, Cravotto G, Palmisano G, Annunziata R, and Szallasi A (1996) Synthesis and evaluation of phorboid 20-homovanillates: discovery of a class of ligands binding to the vanilloid (capsaicin) receptor with different degrees of cooperativity. J Med Chem 39:3123-3131.
2. Bevan S, Hothi S, Hughes G, James IF, Rang HP, Shah K, Walpole CS, and Yeats JC (1992) Capsazepine: a competitive antagonist of the sensory neuron excitant capsaicin. Br J Pharmacol 107:544-552.
3. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, and Julius D (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (Wash DC) 288:306-313.
4. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, and Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (Lond) 389:816-824.
5. Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, Harries MH, Latcham J, Clapham C, Atkinson K, et al. (2000) Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature (Lond) 405:183-187.
6. Docherty RJ, Yeats JC, and Piper AS (1997) Capsazepine block of voltage-gated calcium channels in adult rat dorsal root ganglion neurons in culture. Br J Pharmacol 121:1461-1467.
7. Garcia-Martinez C, Humet M, Planells-Cases R, Gomis A, Caprini M, Viana F, de la Pena E, Sanchez-Baeza F, Carbonell T, De Felipe C, et al. (2002) Attenuation of thermal nociception and hyperalgesia by VR1 blockers. Proc Natl Acad Sci USA 99:2374-2379.
8. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, Cho S, Min KH, Suh YG, Kim D, and Oh U (2000) Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97:6155-6160.
9. Jordt SE, Tominaga M, and Julius D (2000) Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci USA 97:8134-8139.
10. Kim DY and Chancellor MB (2000) Intravesical neuromodulatory drugs: capsaicin and resiniferatoxin to treat the overactive bladder. J Endourol 14:97-103.
11. Kwak J, Wang MH, Hwang SW, Kim TY, Lee SY, and Oh U (2000) Intracellular ATP increases capsaicin-activated channel activity by interacting with nucleotide-binding domains. J Neurosci 20:8298-8304.
12. Kwak JY, Jung JY, Hwang SW, Lee WT, and Oh U (1998) A capsaicin-receptor antagonist, capsazepine, reduces inflammation-induced hyperalgesic responses in the rat: evidence for an endogenous capsaicin-like substance. Neuroscience 86:619-626.
13. Lee J, Lee J, Kang MS, Kim KP, Chung SJ, Blumberg PM, Yi JB and Park YH (2002) Phenolic modification as an approach to improve the pharmacology of the 3-acyloxy-2-benzylpropyl homovanillic amides and thioureas, a promising class of vanilloid receptor agonists and analgesics. Bioorg Med Chem 10:1171-1179.
14. Lee J, Lee J, Kim J, Kim SY, Chun MW, Cho H, Hwang SW, Oh U, Park YH, Marquez VE, Beheshti M, Szabo T and Blumberg PM (2001a) N-(3-acyloxy-2- benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl) thiourea derivatives as potent vanilloid receptor agonists and analgesics. Bioorg Med Chem 9:19-32.
15. Lee J, Lee J, Szabo T, Gonzalez AF, Welter JD, and Blumberg PM (2001b) N-(3- acyloxy-2-benzylpropyl)-N′-dihydroxytetrahydrobenzazepine and tetrahydroiso-quinoline thiourea analogues as vanilloid receptor ligands. Bioorg Med Chem 9:1713-1720.
16. Lee J, Park SU, Kim JY, Kim JK, Lee J, Oh U, Marquez VE, Beheshti M, Wang QJ, Modarres S, and Blumberg PM (1999) 3-Acyloxy-2-phenalkylpropyl amides and esters of homovanillic acid as novel vanilloid receptor agonists. Bioorg Med Chem Lett 9:2909-2914.
17. Liu L and Simon SA (1997) Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine-receptors in rat trigeminal ganglia. Neurosci Lett 228:29-32.
18. Liu L and Simon SA (1996) Similarities and differences in the currents activated by capsaicin, piperine and zingerone in rat trigeminal ganglion cells. J Neurophysiol 76:1858-1869.
19. Matthews JC (1993) Fundamentals of Receptor, Enzyme and Transport Kinetics. pp 64-94, CRC Press, Inc., Boca Raton, Florida.
20. McDonnell ME, Zhang SP, Dubin AE, and Dax SL (2002) Synthesis and in vitro evaluation of a novel iodinated resiniferatoxin derivative that is an agonist at the human VR1 receptor. Bioorg Med Chem Lett 12:1189-1192.
21. Nagy I and Rang HP (1999) Similarities and differences between the responses of rat sensory neurons to noxious heat and capsaicin. J Neurosci 19:10647-10655.
22. Olah Z, Szabo T, Karai L, Hough C, Fields RD, Caudle RM, Blumberg PM, and Iadarola MJ (2001) Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem 276:11021-11030.
23. Premkumar LS and Ahern GP (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature (Lond) 408:985-990.
24. Rains C and Bryson HM (1995) Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 7:317-328.
25. Savidge JR, Ranasinghe SP, and Rang HP (2001) Comparison of intracellular calcium signals evoked by heat and capsaicin in cultured rat dorsal root ganglion neurons and in a cell line expressing the rat vanilloid receptor, VR1. Neuroscience 102:177-184.
26. Smart D and Jerman JC (2000) Anandamide: an endogenous activator of the vanilloid receptor. Trends Pharmacol Sci 21:134.
27. Szallasi A and Blumberg PM (1989) Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 30:515-520.
28. Szallasi A and Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-212.
29. Szallasi A, Blumberg PM, Annicelli LL, Krause JE, and Cortright DN (1999) The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. Mol Pharmacol 56:581-587.
30. Szallasi A, Lewin NE, and Blumberg PM (1992) Identification of alpha-1-acid glycoprotein (orosomucoid) as a major vanilloid binding protein in serum. J Pharmacol Exp Ther 262:883-888.
31. Szallasi A, Sharkey NA, and Blumberg PM (1989) Structure-activity analysis of resiniferatoxin analogs. Phytotherapy Res 6:253-257.
32. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, and Julius D (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531-543.
33. Voilley N, de Weille J, Mamet J, and Lazdunski M (2001) Nonsteroid antiinflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci 21:8026-8033.
34. Wahl P, Foged C, Tullin S, and Thomsen C (2001) Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol Pharmacol 59:9-15.
35. Walpole CS, Wrigglesworth R, Bevan S, Campbell EA, Dray A, James IF, Masdin KJ, Perkins MN, and Winter J (1993a) Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 2. The amide bond "B-region". J Med Chem 36:2373-2380.
36. Walpole CS, Wrigglesworth R, Bevan S, Campbell EA, Dray A, James IF, Masdin KJ, Perkins MN, and Winter J (1993b) Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 3. The hydrophobic side-chain "C-region". J Med Chem 36:2381-2389.
37. Walpole CS, Wrigglesworth R, Bevan S, Campbell EA, Dray A, James IF, Perkins MN, Reid DJ, and Winter J (1993c) Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic "A-region". J Med Chem 36:2362-2372.
38. Wardle KA, Ranson J, and Sanger GJ (1997) Pharmacological characterization of the vanilloid receptor in the rat dorsal spinal cord. Br J Pharmacol 121:1012-1016.
39. Wrigglesworth R, Walpole CS, Bevan S, Campbell EA, Dray A, Hughes GA, James I, Masdin KJ, and Winter J (1996) Analogues of capsaicin with agonist activity as novel analgesic agents: structure-activity studies. 4. Potent, orally active analgesics. J Med Chem 39:4942-4951.
40. Xue Q, Yu Y, Trilk SL, Jong BE, and Schumacher MA (2001) The genomic organization of the gene encoding the vanilloid receptor: evidence for multiple splice variants. Genomics 76:14-20.